Page last updated: 2024-08-18

4-butyrolactone and Squamous Cell Carcinoma of Head and Neck

4-butyrolactone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chung, JG; Hsu, SC; Huang, YP; Kuo, YH; Lin, ML; Yu, CC; Yu, FS	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Squamous Cell Carcinoma of Head and Neck

Article	Year
4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways. International journal of oncology, 2016, Volume: 49, Issue:2 Topics: 4-Butyrolactone; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Squamous Cell Carcinoma of Head and Neck	2016

Article

Year

4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.

International journal of oncology, 2016, Volume: 49, Issue:2

Topics: 4-Butyrolactone; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Squamous Cell Carcinoma of Head and Neck

2016